Company: RNGE
Filing Date: 2025-11-19
Form Type: 424B3
Source: 0001493152-25-024206
Chunk: 0

Company: RANGE IMPACT, INC.
Filing Date: 2025-11-19
Form: 424B3
Chunk 0
---
PROSPECTUS SUPPLEMENT

(To Prospectus dated December 31, 2024)

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-279203

<div align='center'>RANGE IMPACT, INC.

PROSPECTUS

33,166,670 Shares of Common Stock</div>

This prospectus supplement 2 updates, amends and supplements our prospectus dated December 31, 2024 (which was contained in our Registration Statement on Form S-1 (File No. 333-279203) (the “Prospectus”). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 (the “Quarterly Report”). Accordingly, we have attached the Quarterly Report to this prospectus supplement.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

Our common stock is traded on the OTC Markets Group Inc.’s OTCQB tier under the symbol “RNGE”. On November 18, 2025 the closing price of our common stock was $0.16 per share.

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors for our common stock, which are described in the Prospectus, as supplemented.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus supplement is November 19, 2025</div>

<div align='center'>INDEX TO FILINGS</div>

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q</div>

| ☒ | QUARTERLY                                                                     
 REPORT PURSUANT TO SECTION